May 29, 2018 - 8:30 AM EDT
Print Email Article Font Down Font Up Charts

Today's Research Reports on Trending Tickers: Horizon Pharma and The Medicines Company

NEW YORK, NY / ACCESSWIRE / May 29, 2018 / OPEC and major oil-producer Russia were considering an increase in supply, pressuring energy stocks lower. U.S. markets however posted weekly gains on Friday, buoyed by strong performance from the technology shares. The Dow Jones Industrial Average dropped 0.24 percent to close at 24,753.09, while the S&P 500 Index declined 0.24 percent to close at 2,721.33. The Nasdaq Composite Index increased 0.13 percent to close at 7,433.85. For the week, Dow and S&P gained a modest 0.2 percent and 0.3 percent respectively while Nasdaq closed with a strong gain of 1.1 percent.

"If the Saudis do lift oil production, that could be the news of the day. It may result in a weak patch for the energy sector, but for the broader market that could be offset by a rise in sentiment if it results in gas prices falling going into the summer driving season," said John Augustine, chief investment officer at Huntington Private Bank.

RDI Initiates Coverage on:

Horizon Pharma PLC

The Medicines Company

Horizon Pharma's stock jumped 4.19% Friday, to close the day at $16.17. The stock recorded a trading volume of 1,874,108 shares, which was below its three months average volume of 1,904,872 shares. In the last year, Horizon Pharma's shares have traded in a range of 9.90 - 16.19. The share price has gained 63.33% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $14.24 is below its 200-day moving average of $14.48. Shares of Horizon Pharma have gained roughly 20.67 percent in the past month and are up 10.75 percent year-to-date.

Access RDI's Horizon Pharma PLC Research Report at:

On Friday, shares of The Medicines Company recorded a trading volume of 459,886 shares, which was below the three months average volume of 974,140 shares. The stock ended the day 3.26% higher at $32.91. The share price has fallen 24.85% from its 52-week high with a 52-week trading range of 24.45 - 43.79. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $30.46 is above its 200-day moving average of $30.40. Shares of The Medicines Company have gained roughly 8.83 percent in the past month and are up 20.37 percent year-to-date.

Access RDI's The Medicines Company Research Report at:

Our Actionable Research on Horizon Pharma PLC (NASDAQ :HZNP) and The Medicines Company (NASDAQ :MDCO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at


For any questions, inquiries, or comments reach out to us directly at:


Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011


[email protected]

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


Source: ACCESSWIRE Investor Awareness (May 29, 2018 - 8:30 AM EDT)

News by QuoteMedia

Legal Notice